Top Class Actions’s website and social media posts use affiliate links. If you make a purchase using such links, we may receive a commission, but it will not result in any additional charges to you. Please review our Affiliate Link Disclosure for more information.
One of the tipping points in multidistrict litigation (MDL) occurs when a federal judge approves a master complaint for plaintiffs to use. Women who have suffered from Lipitor type-2 diabetes side effects now have that option if they choose to file their Lipitor lawsuits in an MDL centered in U.S. District Court in South Carolina.
Many Lipitor lawsuits feature generally the same allegations. The Lipitor complications lawsuits allege that drug maker Pfizer Inc. knew, or or should have known, of the links between the statin drug and elevated blood sugar levels well before what has been called an inadequate warning label was introduced in 2012. It does not mention type-2 diabetes, but rather fasting serum glucose levels.
However, the new master complaint includes data not often found in other Lipitor diabetes lawsuits. That includes that during clinical trials Lipitor was known to cause elevated blood sugar levels at a rate three times higher than placebo, a fact that is supported by later studies that the drug maker could have used in adjusting its warnings regarding Lipitor type-2 diabetes side effects, according to Lipitor lawsuit lawyers.
The new master complaint notes that in both Japan and Europe, those specific concerns have been addressed. Instead, each new Lipitor lawsuit will note that the effects for women who use the drug to reduce cholesterol levels include a significantly higher risk of death and non-heart-related mortality. There is one other wrinkle found by the Lipitor lawsuit lawyer team that could help plaintiffs.
While legal questions regarding generic drug liability continue, at least one manufacturer is under the gun regarding type-2 diabetes side effects. One of the named defendants is Greenstone, which manufacturers “an authorized generic version” and that “upon information and belief … is a wholly owned subsidiary of Pfizer.”
The Lipitor Type-2 Diabetes MDL is In re: Lipitor (atorvastatin calcium) Marketing, Sales Practices and Products Liability Litigation, MDL No. 2502, in the U.S. District Court for the District of South Carolina.
In general, Lipitor lawsuits are filed individually by each plaintiff and are not class actions.
Do YOU have a legal claim? Fill out the form on this page now for a free, immediate, and confidential case evaluation. The attorneys who work with Top Class Actions will contact you if you qualify to let you know if an individual lawsuit or class action lawsuit is best for you. Hurry — statutes of limitations may apply.
ATTORNEY ADVERTISING
Top Class Actions is a Proud Member of the American Bar Association
LEGAL INFORMATION IS NOT LEGAL ADVICE
Top Class Actions Legal Statement
©2008 – 2024 Top Class Actions® LLC
Various Trademarks held by their respective owners
This website is not intended for viewing or usage by European Union citizens.
Get Help – It’s Free
Join a Free Lipitor Class Action Lawsuit Investigation
If you’re a woman who was diagnosed with type-2 diabetes while taking Lipitor, or were diagnosed with diabetes within 90 days or less of your last dose of Lipitor, you may be eligible for compensation. See if you qualify by filling out the short form below.
An attorney will contact you if you qualify to discuss the details of your potential case at no charge to you.
Oops! We could not locate your form.
